AU4854101A - Medical combinations comprising formoterol and mometasone - Google Patents

Medical combinations comprising formoterol and mometasone

Info

Publication number
AU4854101A
AU4854101A AU48541/01A AU4854101A AU4854101A AU 4854101 A AU4854101 A AU 4854101A AU 48541/01 A AU48541/01 A AU 48541/01A AU 4854101 A AU4854101 A AU 4854101A AU 4854101 A AU4854101 A AU 4854101A
Authority
AU
Australia
Prior art keywords
formoterol
mometasone
medical combinations
medical
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48541/01A
Inventor
Ronique Nichele Garrett
Brian Charles Gavin
Trevor Charles Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU4854101A publication Critical patent/AU4854101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
AU48541/01A 2000-04-18 2001-04-11 Medical combinations comprising formoterol and mometasone Abandoned AU4854101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0009612.3A GB0009612D0 (en) 2000-04-18 2000-04-18 Therapeutic formulations
GB0009612 2000-04-18
PCT/GB2001/001648 WO2001078744A1 (en) 2000-04-18 2001-04-11 Medical combinations comprising formoterol and mometasone

Publications (1)

Publication Number Publication Date
AU4854101A true AU4854101A (en) 2001-10-30

Family

ID=9890191

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48541/01A Abandoned AU4854101A (en) 2000-04-18 2001-04-11 Medical combinations comprising formoterol and mometasone

Country Status (3)

Country Link
AU (1) AU4854101A (en)
GB (1) GB0009612D0 (en)
WO (1) WO2001078744A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002011711A2 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
WO2004019985A1 (en) * 2002-08-29 2004-03-11 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
DE10347994A1 (en) 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Aqueous aerosol preparation
ATE497787T1 (en) 2004-03-12 2011-02-15 Cipla Ltd STERILIZATION PROCESS FOR STEROIDS
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
PE20081788A1 (en) * 2007-02-19 2008-12-18 Cipla Ltd PHARMACEUTICAL COMBINATIONS
WO2011093815A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic Pharmaceutical compositions comprising formoterol and mometasone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
JP2001503772A (en) * 1996-11-11 2001-03-21 セプラクール，インコーポレイテッド Process for the production of optically pure isomers of formoterol
HU226671B1 (en) * 1997-03-20 2009-06-29 Schering Corp Preparation of powder agglomerates
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
GB0009612D0 (en) 2000-06-07
WO2001078744A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU4671601A (en) Medical combinations comprising formoterol and budesonide
AU4672301A (en) Medical combinations comprising formoterol and fluticasone proprionate
AU4853701A (en) Medical combinations comprising tiotropium and budesonide
AU4854001A (en) Medical combinations comprising tiotropium and mometasone
AU4671801A (en) Medical combinations comprising tiotropium and fluticasone proprionate
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU4671501A (en) Medical combinations comprising tiotropium and rofleponide
AU2002356530A1 (en) Medical devices comprising nanomaterials and therapeutic methods utilizing the same
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
SI1757606T1 (en) Xanthinderivatives for use as medical agents and the preparation thereof
AU4854101A (en) Medical combinations comprising formoterol and mometasone
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU4853801A (en) Medical combination comprising salmeterol and budesonide
AU4853601A (en) Medical combinations comprising mometasone and salmeterol
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
PL365582A1 (en) Use of salmeterol and fluticasone propionate combination
GB0011052D0 (en) Medical device and use thereof
AU2002354070A1 (en) Medical polymers and use thereof
AU4671701A (en) Medical compositions comprising (r,r)-formoterol and rofleponide
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001273070A1 (en) Secretion and trafficking molecules

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase